Target intelligence / Profile preview

Arginine and serine rich protein 1 (RSRP1)

Target
RSRP1
Molecular classification
Other (spliceosomal factor, RNA-binding protein)
01

Overview

Arginine and serine rich protein 1 (RSRP1) is a nuclear, RNA-binding protein that serves as a spliceosomal factor, participating in spliceosome assembly and alternative splicing regulation. RSRP1 is enriched in arginine and serine residues and mediates interactions with other spliceosome proteins, notably via serine phosphorylation within its RS domain, particularly at residues S107 and S109. Functionally, RSRP1 regulates the splicing of genes such as PARP6 and contributes to oncogenic phenotypes by facilitating alternative splicing events that promote NF-κB activation, thereby supporting glioblastoma cell invasion, apoptosis resistance, and mesenchymal transdifferentiation. Elevated RSRP1 expression is strongly associated with high-grade gliomas and the aggressive mesenchymal subtype, suggesting a role in tumor progression. While essential in RNA processing and cancer biology, RSRP1 is not currently considered a classic therapeutic target such as a receptor, enzyme, or transporter.

Other names
Arginine/serine-rich protein 1C1orf63HT033NPD014DJ465N24.2.1UPF0471 protein C1orf63D4Ucla2D4Wsu53eLOC101928189LOC105376881RGD1359529
02

Biological functions

Alternative splicing regulationspliceosomal complex assemblyregulation of protein isoform switchingNF-κB pathway modulationfacilitation of cell invasion and apoptosis resistance
03

Disease associations

Cancer (glioblastoma, promotion of the mesenchymal phenotype)Inflammatory bowel disease
04

Biomarkers

Higher expression correlates with glioma grade and mesenchymal glioblastoma subtypes

Beyond the preview

Go deeper on Arginine and serine rich protein 1 (RSRP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine and serine rich protein 1 (RSRP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call